| LDH | Lactic dehydrogenase |
| VEGF | Vascular endothelial growth factor |
| NF-κB | Nuclear factor kappa B |
| PCa | Prostatic cancer |
| KLF6 | Kruppel-like factor 6 |
| Bcl-2 | B-cell lymphoma-2 |
| ROS | Reactive oxygen species |
| MMP-2 | Matrix Metalloproteinase-2 |
| RCC | Renal cell carcinoma |
| HCC | Hepatocellular Carcinoma |
| MVA pathway | Mevalonate pathway |
| TCTP | Translation-controlled tumor protein |
| PCD | Programmed cell death |
| IL-10 | Interleukin-10 |
| NF-κB | Nuclear factor κB |
| IL-1β | Interleukin 1β |
| COX-2 | Cyclooxygenase-2 |
| NSCLC | Non-small cell lung cancer |
| EMT | Epidermal interstitial transformation |
| ESCC | Esophageal squamous cell carcinoma |
| ATC | Anaplastic thyroid carcinoma |
| mTOR | Mammalian target of rapamycin |
| HNC | Head and neck cancer |
| API | Active pharmaceutical ingredient |
| PCa | Prostate cancer |
| AR | Androgen receptor |
| NF1 | Neurofibromatosis type1 |
| MPNST | Malignant peripheral nerve sheath tumors |
| FIGO | International Federation of Gynecology and Obstetrics |
| EC | Esophageal cancer |
| ADM | Doxorubicin |